Once-Daily Venlafaxine XR Compared With Fluoxetine in Outpatients With Depression and Anxiety

Dec 10, 1999The Journal of clinical psychiatry

Comparing once-daily extended-release venlafaxine and fluoxetine in outpatients with depression and anxiety

AI simplified

Psychedelic Science on OpenScience ↗PubMed ↗DOI ↗

Weekly Psychedelic Science Brief

You found one interesting study. We’ll send the next 7.

Get 7 new psychedelic science papers each week, explained in plain English with direct links to the originals.

what lands in your inbox each week:

📚7 fresh studies
📝plain-language summaries
✅direct links to original studies
🏅top journal indicators
📅weekly delivery
🧘‍♂️always free

Recent issues from the psychedelic science brief

Psychedelics disrupt brain signal flow in both humans and mice across LSD, psilocybin, and MDMA

6 days ago7 studies

Psilocybin cut depression scores by 35 points in postpartum mothers

1 week ago7 studies

Psilocybin's antidepressant effects lasted 12 months in 126 treatment-resistant patients

2 weeks ago7 studies

Buprenorphine extends ketamine's anti-suicide effects for 4 weeks in depression trial

3 weeks ago7 studies

Psilocybin helped 18 out of 20 people stay off cocaine for 6 months

5 weeks ago7 studies

Psilocybin reduces specific brain cells' activity while boosting others

6 weeks ago7 studies

Single dose of psilocybin repairs brain circuits in fetal alcohol syndrome mice

7 weeks ago7 studies

Psilocybin's hallucinations and brain rewiring happen through completely different mechanisms

8 weeks ago7 studies

Psilocybin activates the same brain networks across 5 different psychedelics

9 weeks ago7 studies

31% of people with distressing psychedelic experiences met criteria for PTSD

10 weeks ago7 studies

explore the archive

See more issues from the psychedelic science brief